Category: 3. Business

  • Barriers to cloud adoption diminish for financial institutions

    Barriers to cloud adoption diminish for financial institutions

    According to the report by Pinsent Masons, published in partnership with the Financial Regulation Innovation Lab (FRIL), while industry retains some concerns about adopting cloud-based solutions, such as over whether their older systems can be successfully integrated into the cloud environment and over data security, these are “no longer seen as insurmountable blockers”.

    The report explores attitudes, practices and regulation relevant to the use of cloud-based infrastructure and services in financial services – and how they compare to the challenges identified in a different study Pinsent Masons undertook with UK Finance back in 2016.

    At that time, issues concerning the management of data, including around security, was identified as one of seven major hurdles to banks migrating to the cloud. However, while this year’s study, which entailed surveying and interviewing business leaders from organisations operating within the financial services sector, identified data security as one of number of “persistent data challenges”, just a third of survey respondents rated it an important or very important barrier to cloud adoption. In fact, more than 70% of those surveyed said enhanced security is one of the primary drivers for moving to the cloud.

    “The focus [on data security] has shifted to the nuances of the cloud environment,” according to the Pinsent Masons/FRIL report. “This includes managing the network perimeter, the complexities of the shared responsibility model, where ownership ‘wasn’t always clearly mapped out’, and dealing with vendor terms that can be problematic, such as those that ‘won’t accept any liability for loss’ of client data.”

    Other data issues that persist include around the quality of information institutions hold – which is highlighted in the report as a barrier to harnessing the full potential of AI – and around the data localisation requirements imposed by regulators around the world.

    While the study found that there remain some ‘red lines’ for many financial services businesses over the types of functions they are willing to operate from the cloud, just a third of survey respondents said concerns about legacy systems coping with new cloud-based solutions are an important or very important barrier to cloud adoption today.

    Other issues that have been perceived as major hurdles scored even lower on the importance scale, such as around regulatory compliance, vender lock-in, and the cost of migrating systems and data to the cloud.

    Angus McFadyen of Pinsent Masons said: “As we’ve seen with numerous business critical cloud implementations, embedding the shared responsibility model into the organisation can be incredibly challenging – and with the increasing, but still limited, adoption of multi-cloud strategies for resilience purposes this is set to remain an issue for years to come.”

    Mhairi Mival, also of Pinsent Masons, said: “The steady erosion of barriers to cloud adoption in financial services reflects a profound shift in industry priorities. What was once a landscape dominated by concerns over security, compliance, and operational risk is now giving way to confidence in cloud’s ability to deliver resilience, scalability, and regulatory alignment.”

    Yvonne Dunn of Pinsent Masons added: “Risk aversion is, of course, a fundamental aspect of firms’ culture, shaped largely by the regulatory landscape in which they operate. This context has led to hesitation in adopting cloud services. Overcoming this hesitation requires engagement at the highest levels. The long-term cost of inaction and missed opportunities may ultimately outweigh the perceived short-term challenges of technological and cultural transformation.” 

    Continue Reading

  • What is the latest Black Friday boycott – and will it work? | Black Friday

    What is the latest Black Friday boycott – and will it work? | Black Friday

    Building on the momentum of consumer boycotts against Target and other companies earlier this year, grassroots organizers want American consumers to use their economic power this Thanksgiving weekend to protest the Trump administration’s anti-immigration and anti-DEI crackdowns – and the big corporations that won’t oppose them.

    The We Ain’t Buying It campaign – organized by many of the groups behind the No Kings protests – is asking Americans to stop shopping at Target, Home Depot and Amazon on Black Friday, one of the busiest retail days of the year, while also encouraging people to shop local and support community businesses.

    “We are reclaiming our power. We are redirecting our spending. And we are resisting this rise to authoritarianism,” said LaTosha Brown, co-founder of Black Voters Matter, one of the groups spearheading this action.

    Organizers see We Ain’t Buying It as an economic pressure campaign that fits into the broader civil resistance against the president’s agenda. It joins other economic protests launched during the Trump era, including an ongoing boycott against Target for rolling back its DEI policies and an uptick in people cancelling their Disney+ and Hulu subscriptions after ABC’s suspension of late-show host Jimmy Kimmel.

    Consumer activism, including boycotts, can bring meaningful attention to causes, experts said. But whether something like We Ain’t Buying It can prod governments or institutions to change positions depends on what organizers seek to achieve – and how sustained and visible the public pressure.

    “They’re effective not so much because they actually reduce sales that much,” said Nien-hê Hsieh, professor of business administration at Harvard Business School. “But it’s really about calling attention and putting the company in the spotlight.”


    What is We Ain’t Buying It?

    We Ain’t Buying It is targeting three companies, though organizers said they hope to send a message to all businesses willing to cower to the Trump administration.

    On the list is Amazon, which has already faced buying blackouts from groups like the People’s Union USA for donating to Trump’s inaugural fund and reaping major corporate tax cuts. Home Depot is also a target because Immigration and Customs Enforcement (ICE) has reportedly singled out their properties for immigration arrests. Protesters have gathered outside Home Depot locations in US cities such as Charlotte and Chicago to push back against the immigration raids. (Home Depot spokesperson George Lane told the Guardian that the company “isn’t notified that immigration enforcement activities are going to happen, and we aren’t involved in the operations”.)

    Action is also directed at Target for its rollback of its DEI goals, something that has already inspired sustained consumer boycotts this year, especially by Black activists and consumers. In its third-quarter earnings, Target reported a 1.5% drop in net sales, and its stores recorded a 2.2% decline in foot traffic. In August, Target announced its CEO was stepping down, citing inflation, tariffs and the boycott for slipping sales. The company just had its first major layoffs in a decade.

    Organizers plan to keep adding pressure. In addition to Black Voters Matter, groups such as Indivisible, 50501, Until Freedom and the Working Families party have not only helped organize the boycott, but have also been behind the larger civic movements against the second Trump administration. Brown said since the We Ain’t Buying It launch earlier this month, more than 80 other groups have signed on to participate, including labor unions.

    “We’re hoping that the millions of people that participate in this will have a higher level of consciousness of that we have choice, that our money gives us choice,” Brown said. “That means that we have power and that we can make choices to demand better.”

    The weekend boycott begins on Thanksgiving, when the motto is “Don’t spend a dime, spend time with your family,” Brown said. Organizers encourage people not to shop at all on Black Friday, unless it’s at small or local businesses. Shopping locally is also the goal for Saturday. Sunday is focused on mutual aid, and Cyber Monday will be a “cyber shutdown”, Brown said, meaning no online shopping.

    “We have people who are deleting their apps,” Brown said. “We’re going to cancel subscriptions. We’re not buying anything.”


    What is the goal of the boycott?

    The We Ain’t Buying It organizers see this campaign as bigger than a boycott of these specific companies. The campaign is asking participants to reinvest back into their communities and pledge to be conscious consumers. They’ve released a toolkit for partners, and are encouraging people to post on social media.

    Even if We Ain’t Buying It ends after Monday, organizers see this economic pressure as one of the many tools to deploy to counter the Trump administration and protect American democracy. “It’s actually a relay race. It’s a hand-off between different actions and different groups,” said Hunter Dunn, national press coordinator for 50501.

    Dunn said that includes mass mobilizations, like the recent No Kings protest, as well as local organizing, mutual aid and consumer activism, such as boycotts.

    “We need to push back against this administration and the billionaire elites backing it,” Dunn said. “This is just one piece of a larger puzzle.”


    How effective are these kinds of consumer boycotts?

    We Ain’t Buying It joins a tradition of Black Friday protests that have sought to raise awareness about everything from the climate crisis, to worker and labor rights, to overconsumption. These actions can raise the salience of these issues, especially among would-be shoppers who care about these causes.

    “We’ve had Black Friday boycotts since Black Friday has been around,” said Emily E LB Twarog, associate professor at the School of Labor and Employment Relations at the University of Illinois Urbana-Champaign. 

    “‘Don’t buy on Black Friday’ because of how workers are being treated in big box stores or around anti-sweatshop campaigns, and now in response to Trump and ICE. I think that they’re worthy of doing, I just don’t know how systemically effective they are.”

    Experts say how successful these efforts are can be difficult to measure – and it can depend a lot on the organizers’ goals. If the aim is to cut into a company’s sales or force it to change its practices, that can be much harder to achieve, especially for digital or one-off protests. But if the goal is attention, consumer activism can be very valuable.

    “Is it to raise awareness right about these things, so that people have a deeper understanding and maybe make some political decisions based on that knowledge?” Twarog said. “Then I think it’s highly effective because you’re able to share that information.”

    Economic activism can help change the practices of governments and institutions, whether it’s the farm workers strikes of the 1960s, or the anti-apartheid boycotts against South Africa in the 1980s, or even the anti-sweatshop protests against Nike in the 1990s. But as Paul Sergius Koku, professor emeritus at Florida Atlantic University College of Business, said: “It has to be sustained over time, and you have to give reasons for people to buy into it.”

    That requires spreading awareness and attention beyond eager activists to include a wide range of participants willing to sacrifice – even by just paying higher prices – for a cause. Plus, Koku said, companies don’t just sit back and take it; they could also do their own public relations or lower prices to counter the opposition.

    Twarog said she expects that the economic impact of many of today’s consumer boycotts are likely regional or localized, possibly in communities most affected by Trump’s policies, such as hers, in Chicago, where ICE is conducting raids and the national guard is deployed. But retailers like Amazon and Target are huge companies that have faced pressure and backlash before. As Twarog put it: “Is it just the cost of doing business – withstanding these trends?”

    Continue Reading

  • Patient Factors Drive Chemotherapy Decision-Making in Metastatic Pancreatic Cancer

    Patient Factors Drive Chemotherapy Decision-Making in Metastatic Pancreatic Cancer

    With multiple chemotherapy regimens approved for the frontline treatment of patients with metastatic pancreatic cancer, patient factors such as performance status and the presence of certain comorbidities can influence the selection of an appropriate regimen for specific patients, according to Shubham Pant, MD, MBBS.

    Frontline Chemotherapy in Metastatic Pancreatic Cancer

    • Frontline chemotherapy options in metastatic pancreatic cancer comprised NALIRIFOX, FOLFIRINOX, and gemcitabine plus nab-paclitaxel.
    • Chemotherapy selection in the frontline setting can be based on patient performance status and other underlying comorbidities.

    Current frontline options include FOLFIRINOX (fluorouracil, oxaliplatin, and irinotecan), gemcitabine plus nab-paclitaxel (Abraxane), and NALIRIFOX (irinotecan liposome [Onivyde], oxaliplatin, 5-fluorouracil, and leucovorin). NALIRIFOX was the regimen most recently added to the frontline armamentarium following its FDA approval in February 20-24, based on data from the phase 3 NAPOLI 3 study.1

    Findings from the NAPOLI 3 showed that patients treated with NALIRIFOX (n = 383) experienced a median overall survival (OS) of 11.1 months (95% CI, 10.0-12.1) compared with 9.2 months (95% CI, 8.3-10.6) for those given gemcitabine plus nab-paclitaxel (n = 387; HR, 0.83; 95% CI, 0.70-0.99; P = .036).2

    At the 2025 ASCO Annual Meeting, findings from a post hoc analysis of NAPOLI 3 showed that 12.5% of North American patients treated with NALIRIFOX during the study (n = 120) experienced an OS of at least 18 months.3 In this analysis of long-term survivors, investigators showed that most patients needed dose reductions of liposomal irinotecan (66.7%) and dose delays of liposomal irinotecan (86.7%), along with dose delays (80%) and dose reductions (80%) of oxaliplatin. Investigators concluded that these reductions and/or delays allowed for prolonged exposure to treatment and helped this long-term survivor group achieve a median OS of 19.5 months.

    In an interview with OncLive®, Pant outlined the key factors he examines when selecting a frontline chemotherapy regimen for a patient with metastatic pancreatic cancer, explained how NALIRIFOX fits into the current treatment paradigm, and detailed the possibility of incorporating targeted therapy into the frontline treatment setting.

    Pant is a professor in Department of Gastrointestinal (GI) Medical Oncology of the Division of Cancer Medicine, director of Clinical Research, and a professor in the Department of Investigational Cancer Therapeutics at The University of Texas MD Anderson Cancer Center in Houston.

    OncLive: What are some factors driving first-line chemotherapy selection in metastatic pancreatic cancer?

    Pant: The biggest thing is the performance status of the patient [and] if they have any comorbidities. [For example, treatment decisions can be affected] if they have a neuropathy from diabetes, or, overall, if they have any other core issues, like nausea, vomiting, or other comorbidities leading into [treatment]. Those are the two big [factors]. I [consider] the ECG, the performance status, and any comorbidities at the same time in a patient.

    How has NALIRIFOX been integrated into the frontline treatment setting for metastatic pancreatic cancer since its FDA approval in February 2024? Has there any been any challenges adopting that regimen alongside FOLFIRINOX and gemcitabine plus nab-paclitaxel?

    NALIRIFOX was compared [with] gemcitabine and nab-paclitaxel [in the NAPOLI 3 trial] and was found to be a superior regimen [in terms of OS (HR, 0.84; 95% CI, 0.71-0.99; P = .0403) and progression-free survival (HR, 0.70; 95% CI, 0.59-0.85; P = .0001)]. And interestingly, NALIRIFOX has a lower chance of [inducing] neuropathy because of a lower dose of oxaliplatin that was used in [NAPOLI 3].

    However, we do have to watch out for diarrhea in our patients [treated with NALIRIFOX], which can be slightly increased. If a patient is already having diarrhea issues with gut intolerance, then we would tend to use another alternative regimen. Otherwise, I think [NALIRIFOX] a very appropriate regimen for patients in the frontline setting.

    As the research continues to progress, how do you see targeted therapies or other agents impacting the first-line treatment paradigm in metastatic pancreatic cancer?

    That is a great question because we have a lot of targeted agents that are coming into the field. The ones that are furthest along are the pan-RAS inhibitors, [including] a drug called daraxonrasib [RMC-6236], which is [being evaluated] in the phase 3 [RASolute 302] clinical trial [NCT06625320] in the second-line setting [for patients with metastatic pancreatic ductal adenocarcinoma].

    Then we have a number of KRAS G12D inhibitors; approximately 40% of [patients with] pancreatic cancer [harbor KRAS G12D mutations], and we are testing [KRAS G12D inhibitors] as single agents and in combinations of chemotherapy. All that means that there is a lot of excitement in the pancreatic cancer space, and hopefully we should get more options for our patients in the near future.

    With November being Pancreatic Cancer Awareness Month, what would be your message for your colleagues regarding the push to integrate new treatment approaches in the space?

    [Clinicians] should, when appropriate, conduct next-generation sequence testing. And if a patient is appropriate for clinical trials, we should try to find a clinical trial for them. That’s important. Hope is on the horizon for this disease, and hopefully, we should be able to get some newer therapeutics for our patients.

    References

    1. FDA approves irinotecan liposome for first-line treatment of metastatic pancreatic adenocarcinoma. FDA. February 13, 2024. Accessed November 23, 2025. https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-irinotecan-liposome-first-line-treatment-metastatic-pancreatic-adenocarcinoma
    2. Wainberg ZA, Melisi D, Macarulla T, et al. NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial. Lancet. 2023;402(10409):1272-1281. doi:10.1016/S0140-6736(23)01366-1
    3. NAPOLI 3 phase 3 study of NALIRIFOX in metastatic pancreatic ductal adenocarcinoma: characteristics of the long-term survivors. J Clin Oncol. 2025;43(suppl 17):LBA4175. doi:10.1200/JCO.2025.43.17_suppl.LBA4175

    Continue Reading

  • U.S. Natural Gas Futures Start Week Lower – The Wall Street Journal

    1. U.S. Natural Gas Futures Start Week Lower  The Wall Street Journal
    2. European Gas Drops Below €30 for the First Time Since May 2024  Bloomberg.com
    3. EUR: Lower energy costs lift euro’s terms of trade to yearly high – ING  FXStreet
    4. TTF Prices Fall Below €30/MWh  TradingView
    5. European benchmark hits 18-month low on milder outlook, Ukraine peace talks  TradingView

    Continue Reading

  • Google’s Having the AI Build the UI in Latest Gemini Update

    Google’s Having the AI Build the UI in Latest Gemini Update

    Welcome to Tech In Depth, our daily newsletter about the business of tech from Bloomberg’s journalists around the world. Today, Austin Carr looks at Google’s decision to outsource interface design to its ever-evolving Gemini tools.

    Yesteryear’s best: The Trump administration has talked internally about letting Nvidia sell its H200 AI chips in China. The export restrictions on powerful AI chips have been among the most contentious issues of the US-China trade dispute.

    Continue Reading

  • Michael Burry launches newsletter to lay out his AI bubble views after deregistering hedge fund

    Michael Burry launches newsletter to lay out his AI bubble views after deregistering hedge fund

    Michael Burry attends the New York premiere of “The Big Short” at the Ziegfeld Theater in New York City on Nov. 23, 2015.

    Jim Spellman | WireImage | Getty Images

    Michael Burry, the investor who shot to fame for calling the housing crash before 2008, has launched a Substack newsletter after deregistering his hedge fund, aiming to lay out in detail his increasingly bearish thesis on artificial intelligence.

    “The Big Short” investor is capitalizing on the massive audience he’s built on X, where 1.6 million followers have long parsed his cryptic posts. His new publication, titled “Cassandra Unchained” with a $379 annual subscription fee, arrives with a familiar warning: He believes markets are once again deep in bubble territory.

    In announcing the launch, Burry referenced the parallels between the late-1990s tech mania and today’s rush into AI and how the bubbles have been ignored by policymakers, in his view.

    Feb 21, 2000: SF Chronicle says I’m short Amazon. Greenspan 2005: ‘bubble in home prices … does not appear likely.’ [Fed Chair Jerome] Powell ’25: ‘AI companies actually… are profitable… it’s a different thing. ‘I doubted if I ever should come back. I’m back. Please join me,” Burry wrote in a post Sunday night on X.

    He highlighted then-Fed Chair Alan Greenspan’s 2005 insistence that U.S. housing prices showed no signs of a bubble, just two years before the subprime implosion validated Burry’s famous “Big Short.” And now he argues history is rhyming again.

    Like the dot-com era, investors are extrapolating exponential growth, dismissing profitability concerns and funding massive capital expenditures on the assumption that the technology will rewrite the economy, he believes.

    The investor noted Powell has waved off bubble fears, saying that AI companies are “actually profitable” and “a different thing” from past booms,

    “This is different in the sense that these companies, the companies that are so highly valued, actually have earnings and stuff like that,” Powell said during a news conference in October.

    Burry took it as an eerie echo of the assurances offered by Greenspan two decades ago. At the height of the dot-com boom, Burry was publicly short Amazon. Today, he has been openly bearish on the poster children of the AI boom, Nvidia and Palantir.

    Continue Reading

  • Amazon Leo introduces Ultra antenna with 1 Gbps speeds, begins enterprise preview

    Amazon Leo introduces Ultra antenna with 1 Gbps speeds, begins enterprise preview

    Amazon Leo is designed to extend reliable, high-speed internet to those beyond the reach of existing networks, including the millions of businesses, government entities, and organizations operating in places without reliable connectivity. Amazon Leo will help close critical connectivity gaps across major industries, from energy and manufacturing to media and transportation, and these announcements represent another important step for the program as it moves from the deployment phase toward commercial operations.

    Continue Reading

  • The transformative power of AI: Europe’s moment to act

    The transformative power of AI: Europe’s moment to act

    Speech by Christine Lagarde, President of the ECB, BratislavAI Forum on artificial intelligence and education as part of an OECD high-level event to mark the 25th anniversary of “Better Policies for Better Lives”, Bratislava

    Bratislava, 24 November 2025

    It’s a privilege to speak with you today about artificial intelligence.

    In 1987 Robert Solow famously remarked that “you can see the computer age everywhere but in the productivity statistics.”

    The same observation could be made today. We see AI advancing at remarkable speed. Yet its aggregate impact is still barely visible in the data.

    Over the past year global corporate investment in AI reached USD 252 billion, and private AI firms raised a record USD 100 billion.[1] Five leading US investors in terms of capital expenditure are now companies that focus heavily on AI. None of these companies numbered among the top ten investors a decade ago. [2]

    Some view this surge as temporary exuberance running ahead of underlying fundamentals. But a debate framed only in terms of short-term ups and downs may miss the bigger picture.

    History offers many examples of intense investment waves that – despite swings in the investment cycle – ultimately left behind transformative technologies that reshaped economies for decades.[3]

    So the key question is not whether there are cycles – that is almost certain – but how long it will take before the enduring productivity benefits become visible.

    And there are reasons to believe AI could spread faster, and deliver tangible economic gains sooner, than previous technology waves.

    If that is the path we are on – and I believe it may be – Europe needs to position itself accordingly. We need to remove all the obstacles that stop us from embracing this transformation. Otherwise we risk letting the wave of AI adoption pass us by and jeopardise Europe’s future.

    History shows: disruptions first, benefits later

    To understand what is at stake, it is useful to look at history.

    Earlier general purpose technologies, such as electricity, computers or the internet, followed a recognisable trajectory. Disruption arrived early, with broad-based productivity gains only emerging slowly.[4]

    For example, it took around thirty years before the impact of electricity showed up clearly across the economy. Power grids had to be built, factories redesigned and workers reallocated from legacy tasks to new ones.

    Computers, too, required long-term investments in hardware, software, skills and new business models before they translated into measurable improvements.

    If Europe’s AI wave resembles the spread of electricity in the 1920s, annual productivity growth could be about 1.3 percentage points higher. But if it follows the US digital boom of the late 1990s, the boost would be closer to 0.8 points.[5] Even that lower bound would be significant for Europe, marking a clear step up from recent trend productivity.

    Could this time be different?

    But AI has features that could compress this cycle and push forward even greater productivity gains. Two features – innovation and diffusion – point to a faster path.

    The first is that frontier innovation may accelerate because of the recursive nature of AI.

    AI systems can use their own output to enhance their performance in a continuous loop. This can lower not only the cost of producing goods and services, but also the cost of generating new ideas.[6]

    For instance, in fifty years, science resolved approximately 200,000 protein structures. AI achieved over 200 million protein structure predictions in about one year, vastly expanding the knowledge frontier.[7]

    This represents a significant change in the inputs to research and development. As the knowledge base expands almost overnight, downstream discovery can compound sooner, even before every lab or firm has fully reorganised.

    By accelerating the production of ideas, AI can lift not just the level of productivity but potentially the growth rate itself.[8] Some estimates suggest that such AI-augmented R&D could double recent US productivity growth rates to between 1.6 and 2.4% annually – faster than previous technology waves.[9]

    Second, the diffusion of AI technologies can be faster because much of the supporting infrastructure already exists.

    It is true that there are bottlenecks. The current wave of investment in hyperscalers shows that compute capacity remains a constraint. Training and deploying larger models requires substantial investment in data centres and energy. In Europe we face particular challenges in this respect, given our higher energy costs and longer permitting delays.

    But unlike past technologies, such as electricity or computers that required new physical networks or coding skills, AI runs on existing internet devices and communicates with users through human language.

    Wide-scale use can therefore proceed even before the infrastructure build-out is complete. Many AI applications already deliver gains on existing hardware. So while a lack of computing capacity holds back the pace of model development, it does not necessarily block diffusion across the wider economy.[10]

    Moreover, the infrastructure itself is advancing quickly. While Moore’s Law forecasts a doubling in chip capacity every two years, AI model compute power has been doubling every six months – four times faster.

    What Europe stands to gain

    What does this mean for Europe?

    The stakes could be extraordinarily high.

    With the United States and China ahead of the field, Europe has already missed the opportunity to be a first mover in AI. And we still bear the costs of having been slow adopters during the last digital revolution. We cannot afford to make the same mistake again.

    Yet the story is far from over. Europe can still emerge as a strong second mover if it acts decisively. Our goal should not be to out-build the leading AI models, but rather to deploy AI across the board. By focusing on rapid adoption and smart use of existing AI technologies across our wide-ranging industries, Europe can turn a late start into a competitive edge.[11]

    Our economy is highly diversified. The top ten firms in the US stock market account for roughly 40% of the market across just four sectors, whereas the top ten in the EU account for no more than 18% across almost twice as many sectors.

    And European firms are already adopting generative AI on a similar scale to those in the United States. What the ECB is hearing from large European companies confirms this trend: many are investing heavily in databases, cloud solutions and AI, with providers of these services reporting double-digit growth.[12]

    But to turn these benefits into a competitive advantage, we need to connect data across sectors. Thanks to industrial-scale data spaces, companies can share operational data and create training sets for AI models that no single firm could assemble alone.[13]

    Initiatives like Manufacturing-X and Catena-X in the automotive sector foster collaboration in data sharing, while the European Health Data Space enables interoperable health records, allowing us to leverage the broad anonymised patient datasets generated by our universal healthcare systems.[14]

    But these efforts will not be enough on their own.

    If our data spaces use technology stacks that are owned and governed outside Europe, we deepen – rather than reduce – our strategic dependencies. We must diversify critical parts of the AI supply chain and avoid single points of failure. In the foundational layers, such as compute capacity based on chips and data centres, we should maintain a minimum capacity.

    In the application layer, Europe should leverage the power of the Single Market to enforce interoperability and open standards. This will encourage competition among large models and prevent the kind of “lock-in” that has occurred with technology platforms in the past.

    Moreover, we must overcome a familiar set of old barriers that have prevented us from being first movers in the past.

    If we allow our energy costs to stay high, if regulations remain fragmented, and if capital markets fail to integrate and channel long-term, risk-bearing funding at scale, AI will diffuse more slowly.

    And this time, the consequences extend beyond losing the race in AI models. We would eventually face a further loss of competitiveness for many of our sectors and industries.

    Conclusion

    Let me conclude.

    “It’ll be ten times bigger than the Industrial Revolution – and maybe ten times faster.” These words from Demis Hassabis – joint winner of the 2024 Nobel Prize in Chemistry for his AI research – capture the potential scale and speed of what may lie ahead.

    So the question is no longer whether this new frontier will arrive, but how soon – and the pace of progress in recent years suggests it is likely to be sooner than our institutions and regulations are prepared for.

    That means acting now to clear the obstacles that would slow AI diffusion and so delay prosperity for all Europeans in the decades ahead.

    Continue Reading

  • Intercontinental Exchange (ICE) and Benchmark (BMI) Launch Lithium and Cobalt Futures Contracts

    Intercontinental Exchange (ICE) and Benchmark (BMI) Launch Lithium and Cobalt Futures Contracts

    Intercontinental Exchange (NYSE: ICE) and Benchmark Mineral Intelligence (BMI) today – Monday 24 November – announce the launch of new lithium and cobalt futures contracts settled against Benchmark’s trade‑verified price assessments.

    Their listing on ICE Futures  Europe represents another milestone in the maturation of the battery metals market – connecting dependable physical market benchmarks to globally regulated trading venues.

    Closing the basis risk gap

    For many commercial participants in the battery metal supply chain, aligning physical market pricing with financial market instruments has been challenging.

    Variations between different reference prices have created measurable basis risk and made it difficult for some treasuries to achieve hedge accounting treatment under IFRS guidelines.

    The Benchmark (BMI) futures contracts on ICE, settled against Benchmark’s IOSCO‑assured, transaction‑based assessments, now offer a route to closer alignment between physical exposures and financial hedges.

    This development improves pricing transparency and provides corporate and financial users with the tools to manage lithium and cobalt price risk more effectively across both physical and derivative markets.

    “These contracts expand, rather than compete with, existing lithium and cobalt derivatives by addressing an unmet hedging need for the majority of the ex‑China supply chain,” shared Daniel Fletcher-Manuel, Benchmark’s Director of Indexing & Derivatives.

    “They provide a transparent, regulated pathway for manufacturers, producers, and investors to manage battery metal price exposure across the same indices that underpin billions of dollars in offtake and supply agreements” he added.

    Benchmark Chief Operating Officer, Caspar Rawles, commented:

    “For the first time, participants across the supply chain, from producers to consumers and financial institutions, can trade using Benchmark’s market leading, trusted price assessments, backed by years of independent data, analysis, and market specific methodologies.This is a defining step for the global energy transition.

    “By bringing transparent and independently verified transaction prices for lithium and cobalt to regulated futures markets, we’re helping to build confidence, manage risk, and support the sustainable growth of supply chains powering these new energy supply chains.”

    About the partnership

    Intercontinental Exchange (ICE) operates some of the world’s leading exchanges and clearing houses, including ICE Futures Europe, ICE Futures U.S., and the New York Stock Exchange.

    Benchmark Mineral Intelligence is the independent data provider for the lithium‑ion battery and energy transition supply chain, publishing daily trade‑verified, IOSCO‑assured price assessments used widely in global physical and financial contracts.

    The BMI futures contract suite includes:

    • Lithium Carbonate CIF Asia (BMI) Future

    • Lithium Hydroxide CIF Asia (BMI) Future

    • Spodumene Concentrate FOB Australia (BMI) Future

    • Cobalt Hydroxide CIF Asia (BMI) Future

    These futures contracts connect transparent price discovery with regulated market infrastructure, enabling effective hedging for the world’s battery metal supply chain.

    Learn more about BMI lithium futures or BMI cobalt futures and start trading today.

    Continue Reading

  • Powering Romania’s Nuclear Energy Ambitions

    This expansion is a critical part of Romania’s national energy strategy, which takes a holistic approach to energy security and related economic growth goals. It also aligns with the EU’s clean energy targets for 2030, which include decreasing greenhouse gas emissions by at least 40%.1

    “The construction funded by these two deals is anticipated to do more than increase the plant’s power generation. It is expected to lead to a reduction of up to 10 million tons of greenhouse gas emissions per year,” said Anna-Mariya Duncheva, the client executive for SNN and a member of the J.P. Morgan Investment Banking team in EMEA

    The project has received strong support from the Romanian government and international partners including the United States and Canada. The use of CANDU reactor technology and potential to collaborate with leading nuclear technology firms ensure that innovation, safety, and efficiency are prioritized as the project moves ahead. 

    “It is our objective to deliver safe, available energy as planned, no delays, no cost overruns,” said Cosmin Ghita, chief executive officer at Nuclearelectrica. “This partnership is a recognition of the robustness of both projects and a reconfirmation of the complex role nuclear energy is to play on the long run, which I call trust, and I thank J.P. Morgan and the banking institutions for their professionalism and partnership.”  

    “This deal supports the EU’s wider shift toward renewable energy,” said Milena Grayde, head of investment banking for Romania. “Nuclear provides 9% of the world’s energy2. Currently, SNN meets 20% of electricity demand in Romania through nuclear energy, more than double the global ratio. When both projects are finished, that number is expected to climb to 40%.”

    Emre Tuzun, who leads Central and Eastern European corporate banking, agrees. “This deal not only furthers Romania’s energy independence agenda but also demonstrates our commitment to advancing the EU’s climate objectives and supporting our clients across the region.”

    Continue Reading